So concerning warrants and shorts etc driving the
Post# of 148288
If I were a Gilead or some other entity threatened by Leronlimab in an open OTC market, I think I would be able to figure out a way to mow the grass on a chart. My organization could sell or short every time CYDY spiked. We could keep the ceiling near the floor with all of our BP funds and our interests at stake.
By doing this, we might reduce investor confidence, drive negative PR and volatility, defend against an up listing to a major index, and increase my own leverage in a buyout proposition.
Is it bigger than warrants? Bigger than shorts?
Maybe I’m too cynical, but I am Big Picture.
Thoughts?